{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:13:15Z","timestamp":1790935995216,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":42,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642335693","type":"print"},{"value":"9783642335709","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-33570-9_13","type":"book-chapter","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T12:31:22Z","timestamp":1355401882000},"page":"287-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transforming the Domain Structure of Botulinum Neurotoxins into Novel Therapeutics"],"prefix":"10.1007","author":[{"given":"John","family":"Chaddock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","volume":"362","author":"JW Arndt","year":"2006","unstructured":"Arndt JW, Jacobson MJ, Abola EE, Forsyth CM, Tepp WH, Marks JD, Johnson EA, Stevens RC (2006) A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1\u2013A4. J Mol Biol 362:733\u2013742","journal-title":"J Mol Biol"},{"issue":"6","key":"13_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1471-4159.2004.02844.x","volume":"91","author":"S Bade","year":"2004","unstructured":"Bade S, Rummel A, Reisinger C, Karnath T, Ahnert-Hilger G, Bigalke H, Binz T (2004) Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates. J Neurochem 91(6):1461\u20131472","journal-title":"J Neurochem"},{"issue":"6","key":"13_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/1061186310001634667","volume":"11","author":"M Box","year":"2003","unstructured":"Box M, Parks DA, Knight A, Hale C, Fishman PS, Fairweather NF (2003) A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells. J Drug Target 11(6):333\u2013343","journal-title":"J Drug Target"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2164-10-115","volume":"10","author":"AT Carter","year":"2009","unstructured":"Carter AT, Paul CJ, Mason DR, Twine SM, Alston MJ, Logan SM, Austin JW, Peck MW (2009) Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 10:115","journal-title":"BMC Genomics"},{"issue":"2","key":"13_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/08977190009003240","volume":"18","author":"JA Chaddock","year":"2000","unstructured":"Chaddock JA, Purkiss JR, Duggan MJ, Quinn CP, Shone CC, Foster KA (2000a) A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitter release in vitro. Growth Factors 18(2):147\u2013155","journal-title":"Growth Factors"},{"issue":"5","key":"13_CR6","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/IAI.68.5.2587-2593.2000","volume":"68","author":"JA Chaddock","year":"2000","unstructured":"Chaddock JA, Purkiss JR, Friis LM, Broadbridge JD, Duggan MJ, Fooks SJ, Shone CC, Quinn CP, Foster KA (2000b) Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A. Infect Immun 68(5):2587\u20132593","journal-title":"Infect Immun"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1046-5928(02)00002-5","volume":"25","author":"JA Chaddock","year":"2002","unstructured":"Chaddock JA, Herbert MH, Ling RJ, Alexander FCG, Fooks SJ, Revell DF, Quinn CP, Shone CC, Foster Ka (2002) Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. Protein Expr Purif 25:219\u2013228","journal-title":"Protein Expr Purif"},{"issue":"Suppl 8","key":"13_CR8","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/mds.20008","volume":"19","author":"JA Chaddock","year":"2004","unstructured":"Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Duggan MJ, Quinn CP, Shone CC, Foster KA (2004) Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Mov Disord 19(Suppl 8):S42\u2013S47","journal-title":"Mov Disord"},{"issue":"23","key":"13_CR9","doi-asserted-by":"publisher","first-page":"9180","DOI":"10.1073\/pnas.0903111106","volume":"106","author":"S Chen","year":"2009","unstructured":"Chen S, Barbieri JT (2009) Engineering botulinum neurotoxin to extend therapeutic intervention. Proc Natl Acad Sci USA 106(23):9180\u20139184","journal-title":"Proc Natl Acad Sci USA"},{"issue":"42","key":"13_CR10","doi-asserted-by":"publisher","first-page":"18197","DOI":"10.1073\/pnas.1007125107","volume":"107","author":"F Darios","year":"2010","unstructured":"Darios F, Niranjan D, Ferrari E, Zhang F, Soloviev M, Rummel A, Bigalke H, Suckling J, Ushkaryov Y, Naumenko N, Shakirzyanova A, Giniatullin R, Maywood E, Hastings M, Binz T, Davletov B (2010) SNARE tagging allows stepwise assembly of a multimodular medicinal toxin. Proc Natl Acad Sci USA 107(42):18197\u201318201","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"13_CR11","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1111\/j.1742-4658.2011.08205.x","volume":"278","author":"JO Dolly","year":"2011","unstructured":"Dolly JO, Wang J, Zurawski TH, Meng J (2011) Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators. FEBS J 278(23):4454\u20134466","journal-title":"FEBS J"},{"issue":"12","key":"13_CR12","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.3390\/toxins2122872","volume":"2","author":"DB Drachman","year":"2010","unstructured":"Drachman DB, Adams RN, Balasubramanian U, Lu Y (2010) Strategy for treating motor neuron diseases using a fusion protein of botulinum toxin binding domain and streptavidin for viral vector access: work in progress. Toxins (Basel) 2(12):2872\u20132889","journal-title":"Toxins (Basel)"},{"issue":"38","key":"13_CR13","doi-asserted-by":"publisher","first-page":"34846","DOI":"10.1074\/jbc.M202902200","volume":"277","author":"MJ Duggan","year":"2002","unstructured":"Duggan MJ, Quinn CP, Chaddock JA, Purkiss JR, Alexander FC, Doward S, Fooks SJ, Friis LM, Hall YH, Kirby ER, Leeds N, Moulsdale HJ, Dickenson A, Green GM, Rahman W, Suzuki R, Shone CC, Foster KA (2002) Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J Biol Chem 277(38):34846\u201334852","journal-title":"J Biol Chem"},{"issue":"4","key":"13_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/toxins3040345","volume":"3","author":"E Ferrari","year":"2011","unstructured":"Ferrari E, Maywood ES, Restani L, Caleo M, Pirazzini M, Rossetto O, Hastings MH, Niranjan D, Schiavo G, Davletov B (2011) Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity. Toxins (Basel) 3(4):345\u2013355","journal-title":"Toxins (Basel)"},{"issue":"12","key":"13_CR15","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/toxins2122795","volume":"2","author":"KA Foster","year":"2010","unstructured":"Foster KA, Chaddock JA (2010) Targeted secretion inhibitors\u2014innovative protein therapeutics. Toxins 2(12):2795\u20132815","journal-title":"Toxins"},{"issue":"2\u20133","key":"13_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03354881","volume":"9","author":"KA Foster","year":"2006","unstructured":"Foster KA, Adams EJ, Durose L, Cruttwell CJ, Marks E, Shone CC, Chaddock JA, Cox CL, Heaton C, Sutton JM, Wayne J, Alexander FC, Rogers DF (2006) Re-engineering the target specificity of Clostridial neurotoxins\u2014a route to novel therapeutics. Neurotox Res 9(2\u20133):101\u2013107","journal-title":"Neurotox Res"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/bi801686b","volume":"48","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Jacobson M, Tepp W, Pier C, Ea Johnson, Barbieri JT (2009) Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 48:2522\u20132528","journal-title":"Biochemistry"},{"issue":"3","key":"13_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/JB.01180-06","volume":"189","author":"KK Hill","year":"2007","unstructured":"Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, Svensson RT, Brown JL, Johnson EA, Smith LA, Okinaka RT, Jackson PJ, Marks JD (2007) Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 189(3):818\u2013832","journal-title":"J Bacteriol"},{"issue":"37","key":"13_CR19","doi-asserted-by":"publisher","first-page":"10685","DOI":"10.1021\/bi701162d","volume":"46","author":"R Jin","year":"2007","unstructured":"Jin R, Sikorra S, Stegmann CM, Pich A, Binz T, Brunger AT (2007) Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity. Biochemistry 46(37):10685\u201310693","journal-title":"Biochemistry"},{"issue":"1","key":"13_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","volume":"386","author":"D Kumaran","year":"2009","unstructured":"Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S (2009) Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J Mol Bio 386(1): 233\u2013245","journal-title":"J Mol Bio"},{"issue":"5","key":"13_CR21","doi-asserted-by":"publisher","first-page":"e20352","DOI":"10.1371\/journal.pone.0020352","volume":"6","author":"CL Kuo","year":"2011","unstructured":"Kuo CL, Oyler GA, Shoemaker CB (2011) Accelerated neuronal cell recovery from botulinum neurotoxin intoxication by targeted ubiquitination. PLoS One 6(5):e20352","journal-title":"PLoS One"},{"issue":"10","key":"13_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"DB Lacy","year":"1998","unstructured":"Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5(10):898\u2013902","journal-title":"Nat Struct Biol"},{"issue":"1","key":"13_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2009.02.003","volume":"381","author":"G Masuyer","year":"2009","unstructured":"Masuyer G, Thiyagarajan N, James PL, Marks PM, Chaddock JA, Acharya KR (2009) Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. Biochem Biophys Res Commun 381(1):50\u201353","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"13_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jsb.2010.11.010","volume":"174","author":"G Masuyer","year":"2011","unstructured":"Masuyer G, Beard M, Cadd VA, Chaddock JA, Acharya KR (2011a) Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. J Struct Biol 174(1):52\u201357","journal-title":"J Struct Biol"},{"issue":"Pt 12","key":"13_CR25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1107\/S1744309111034671","volume":"67","author":"G Masuyer","year":"2011","unstructured":"Masuyer G, Stancombe P, Chaddock JA, Acharya KR (2011b) Structures of engineered Clostridium botulinum neurotoxin derivatives. Acta Crystallogr, Sect F: Struct Biol Cryst Commun 67(Pt 12):1466\u20131472","journal-title":"Acta Crystallogr, Sect F: Struct Biol Cryst Commun"},{"issue":"13","key":"13_CR26","first-page":"3233","volume":"125","author":"L Peng","year":"2012","unstructured":"Peng L, Berntsson RP, Tepp WH, Pitkin RM, Johnson EA, Stenmark P, Dong M (2012) Botulinum neurotoxin D-C uses synaptotagmin I\/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins. J Cell Sci 125(13): 3233\u20133245","journal-title":"J Cell Sci"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/toxins3010063","volume":"3","author":"A Pickett","year":"2011","unstructured":"Pickett A, Perrow K (2011) Towards new uses of botulinum toxin as a novel therapeutic tool. Toxins 3:63\u201381","journal-title":"Toxins"},{"issue":"1","key":"13_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","volume":"585","author":"CL Pier","year":"2011","unstructured":"Pier CL, Chen C, Tepp WH, Lin G, Janda KD, Barbieri JT, Pellett S, Johnson EA (2011) Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett 585(1):199\u2013206","journal-title":"FEBS Lett"},{"issue":"3","key":"13_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","volume":"51","author":"A Rummel","year":"2004","unstructured":"Rummel A, Mahrhold S, Bigalke H, Binz T (2004) The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 51(3):631\u2013643","journal-title":"Mol Microbiol"},{"issue":"23","key":"13_CR30","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1111\/j.1742-4658.2011.08196.x","volume":"278","author":"A Rummel","year":"2011","unstructured":"Rummel A, Mahrhold S, Bigalke H, Binz T (2011) Exchange of the H(CC) domain mediating the double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin. FEBS J 278(23):4506\u20134515","journal-title":"FEBS J"},{"issue":"1","key":"13_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","volume":"17","author":"AB Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 17(1):21\u201325","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1210\/er.2011-0002","volume":"32","author":"E Somm","year":"2011","unstructured":"Somm E, Martinez A, Marks P, Toulotte A, Bonnet N, Ferrari S, Huppi P, Jones R, Aubert M (2011) SXN101742, a botulinum toxin-derived targeted secretion inhibitor (TSI) inhibits GH synthesis and secretion: a new concept for the management of acromegaly. Endocr Rev 32:P1\u2013P413","journal-title":"Endocr Rev"},{"issue":"1","key":"13_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","volume":"81","author":"J Strotmeier","year":"2011","unstructured":"Strotmeier J, Gu S, Jutzi S, Mahrhold S, Zhou J, Pich A, Eichner T, Bigalke H, Rummel A, Jin R, Binz T (2011) The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol Microbiol 81(1):143\u2013156","journal-title":"Mol Microbiol"},{"issue":"4","key":"13_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","volume":"586","author":"J Strotmeier","year":"2012","unstructured":"Strotmeier J, Willjes G, Binz T, Rummel A (2012) Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. FEBS Lett 586(4):310\u2013313","journal-title":"FEBS Lett"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pep.2004.06.023","volume":"40","author":"JM Sutton","year":"2005","unstructured":"Sutton JM, Wayne J, Scott-tucker A, Brien SMO, Marks PMH, Alexander FCG, Shone CC, Chaddock JA (2005) Preparation of specifcally activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications. Protein Expr Purif 40:31\u201341","journal-title":"Protein Expr Purif"},{"issue":"Pt 8","key":"13_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1107\/S0907444900006764","volume":"56","author":"S Swaminathan","year":"2000","unstructured":"Swaminathan S, Eswaramoorthy S (2000) Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B. Acta Crystallogr D Biol Crystallogr 56(Pt 8):1024\u20131026","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"38","key":"13_CR37","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1073\/pnas.1008302107","volume":"107","author":"YC Tsai","year":"2010","unstructured":"Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM (2010) Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc Natl Acad Sci USA 107(38):16554\u201316559","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"13_CR38","doi-asserted-by":"publisher","first-page":"16993","DOI":"10.1074\/jbc.M710442200","volume":"283","author":"J Wang","year":"2008","unstructured":"Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A, Bodeker MO, Gilmore MA, Fernandez-Salas E, Francis J, Steward LE, Aoki KR, Dolly JO (2008) Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J Biol Chem 283(25):16993\u201317002","journal-title":"J Biol Chem"},{"issue":"8","key":"13_CR39","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1074\/jbc.M110.181784","volume":"286","author":"J Wang","year":"2011","unstructured":"Wang J, Zurawski TH, Meng J, Lawrence G, Olango WM, Finn DP, Wheeler L, Dolly JO (2011) A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic. J Biol Chem 286(8):6375\u20136385","journal-title":"J Biol Chem"},{"issue":"1","key":"13_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20120100","volume":"444","author":"J Wang","year":"2012","unstructured":"Wang J, Zurawski TH, Bodeker M, Meng J, Boddul S, Aoki KR, Dolly JO (2012) Longer-acting and highly-potent chimeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B. Biochem J 444(1): 59\u201367","journal-title":"Biochem J"},{"issue":"1","key":"13_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0304-3940(91)90210-K","volume":"122","author":"U Weller","year":"1991","unstructured":"Weller U, Dauzenroth ME, Gansel M, Dreyer F (1991) Cooperative action of the light chain of tetanus toxin and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates. Neurosci Lett 122(1):132\u2013134","journal-title":"Neurosci Lett"},{"issue":"48","key":"13_CR42","doi-asserted-by":"publisher","first-page":"10419","DOI":"10.1021\/bi201490t","volume":"50","author":"FL Yeh","year":"2011","unstructured":"Yeh FL, Zhu Y, Tepp WH, Johnson EA, Bertics PJ, Chapman ER (2011) Retargeted clostridial neurotoxins as novel agents for treating chronic diseases. Biochemistry 50(48):10419\u201310421","journal-title":"Biochemistry"}],"container-title":["Current Topics in Microbiology and Immunology","Botulinum Neurotoxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-33570-9_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:05:20Z","timestamp":1710497120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-33570-9_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642335693","9783642335709"],"references-count":42,"aliases":["10.1007\/978-3-662-45790-0_13"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-33570-9_13","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"14 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}